3. As of noon trading, Capital One Financial ( COF) is up $0.46 (0.8%) to $54.66 on light volume Thus far, 1.5 million shares of Capital One Financial exchanged hands as compared to its average daily volume of 5.8 million shares. The stock has ranged in price between $53.84-$54.68 after having opened the day at $54.26 as compared to the previous trading day's close of $54.20.

Capital One Financial Corporation operates as the bank holding company for the Capital One Bank (USA), National Association (COBNA), and Capital One, National Association (CONA), which provide various financial products and services in the United States, the United Kingdom, and Canada. Capital One Financial has a market cap of $31.7 billion and is part of the financial services industry. The company has a P/E ratio of 8.3, below the S&P 500 P/E ratio of 17.7. Shares are down 6.4% year to date as of the close of trading on Friday. Currently there are 19 analysts that rate Capital One Financial a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Capital One Financial as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in stock price during the past year, increase in net income, attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Capital One Financial Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

AFLAC: If It Looks Like a Duck and Quacks Like a Bull...

Market Recon: The Tax Reform Is Just Ordinary Negotiation on Steroids

Analysts' Actions -- Aflac, Tesla, Under Armour, Urban Outfitters and More

Market Recon: Political Risk Shows Signs of Becoming Ongoing Condition

Analysts' Actions -- Autodesk, Aflac, AstraZeneca, Duluth and More